Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2007

01.11.2007 | Society communications

EANM Marie Curie training grant project report PET–CT in oncology imaging

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Excerpt

Positron emission tomography (PET) with computed tomography (CT) is the combination of imaging function and structure. In the past decade, the integration of anatomic and functional imaging has emerged as a new and promising diagnostic tool especially in the field of oncology. The training project was initiated on the June 4, 2007 and was completed on July 3, 2007 at the Clinical PET–CT Center at St. Thomas Hospital, London, UK, which is affiliated with the Guy’s, King’s and St. Thomas’ school of Medicine and Guy’s and St. Thomas’ NHS Foundation trust. This centre was established in 1992 and was the first clinically oriented PET centre in the United Kingdom. The workload at the centre includes more than 90% oncology patients and less than 10% with cardiology, neurology and miscellaneous referrals. …
Literatur
2.
Zurück zum Zitat Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. “Anatometabolic” tumour imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190–7.PubMed Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. “Anatometabolic” tumour imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190–7.PubMed
3.
Zurück zum Zitat Ahuja V, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918–24.PubMedCrossRef Ahuja V, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918–24.PubMedCrossRef
4.
Zurück zum Zitat Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255–60.PubMedCrossRef Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255–60.PubMedCrossRef
5.
Zurück zum Zitat Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22–30.PubMedCrossRef Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22–30.PubMedCrossRef
6.
Zurück zum Zitat Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999;26:226–30.PubMedCrossRef Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999;26:226–30.PubMedCrossRef
7.
Zurück zum Zitat Mikhaeel NG, Hutchings M, Fields PA, O’Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high grade non-Hodgkin’s lymphoma. Ann Oncol 2005;16:1514–23.PubMedCrossRef Mikhaeel NG, Hutchings M, Fields PA, O’Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high grade non-Hodgkin’s lymphoma. Ann Oncol 2005;16:1514–23.PubMedCrossRef
Metadaten
Titel
EANM Marie Curie training grant project report PET–CT in oncology imaging
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0571-6

Weitere Artikel der Ausgabe 11/2007

European Journal of Nuclear Medicine and Molecular Imaging 11/2007 Zur Ausgabe